The sister of a Sydney man who passed away after years of using performance-enhancing drugs (PEDs) is raising awareness of the associated risks, particularly concerning unregulated peptides. Isabella Boutin is determined to ensure that others do not face the same tragic outcome as her brother, Alex Boutin, who died from a heart attack in October 2024 at the age of 33.
:max_bytes(150000):strip_icc():format(jpeg)/alex-boutin-peptides-081026-132f16f8248c4a8190028126795efcee.jpg)
Alex’s death has raised serious questions about the safety of substances that are often used in the pursuit of physical enhancement. Doctors who treated Alex stated that his prolonged use of PEDs would have significantly affected his heart health. Isabella recalled the moment when a friend found Alex collapsed at his home after he had gone out for dinner with friends, marking the beginning of an unimaginable tragedy for their family.

Reflecting on her brother’s experience, Isabella revealed that Alex had started using PEDs during his teenage years. At 17, feeling insecure and recently heartbroken, he sought to improve his physique after being told by a girlfriend that he was “small and a bit skinny.” It was at the gym where he first encountered the allure of PEDs, touted by some as solutions to gain muscle and confidence.

Isabella shared her own naivety, stating that she was unaware of the potential dangers of peptides until just a few years before her brother’s death. He had assured her that these substances were safe, which only added to the deep shock and sorrow she experienced when learning of their hazardous nature. Following Alex’s death, a range of PEDs were discovered in his home, highlighting the serious implications of unregulated drug use.
Peptides, which are short chains of amino acids, are often marketed for various benefits, including muscle building, anti-ageing, and anti-inflammatory effects. However, there remains a significant lack of research verifying their effectiveness and safety. Isabella hopes that sharing her brother’s story will shine a light on the importance of discussing the risks associated with these substances.
Dr. Timothy Piatkowski, a researcher at the University of Queensland, expressed concerns regarding the reliability of unregulated products. His research has shown that many of these substances are either under-dosed or overdosed, with some containing absolutely none of the claimed ingredients. This highlights an alarming gap in quality control that could lead to dangerous health consequences for users.
In light of these dangers, Australia’s Therapeutic Goods Administration (TGA) has initiated a crackdown on unregulated peptides, targeting illegal advertising and distribution channels. Similarly, the U.S. Food and Drug Administration (FDA) has begun taking action against unapproved peptide products, warning that these substances might pose serious and potentially life-threatening risks.
Isabella is now working towards establishing a foundation dedicated to researching the impact of performance-enhancing drugs. Her mission is to raise awareness, particularly in schools and medical centres, about the potential hazards of using peptides and similar substances. She describes sharing her brother’s story as a painful yet crucial task, driven by a desire to prevent others from experiencing similar heartache.
“Out of deep love for him, I want to shine a light on the quiet crisis of body enhancement drug use,” Isabella explained. “These drugs kill. If saving even one life is the ultimate tribute to my brother, then I will do everything I can to bring attention to this issue.”
The loss of Alex Boutin serves as a poignant reminder of the dangers of unregulated substances in the realm of fitness and bodybuilding. As Isabella seeks to honour her brother’s memory, she hopes that her advocacy will lead others to consider the potential risks before using such performance-enhancing drugs.
PEOPLE has reached out to the Therapeutic Goods Administration for further comment but is yet to receive a response. Isabella Boutin’s determination to highlight the dangers of PEDs reflects a growing recognition of the need for greater education and regulation in this area.
